This active immunization study relied on the tau transgenic mouse P301S generated by Yoshiyama et al. which show clasping and limb retraction deficits at an age of three month, followed by limb weakness and brain atrophy and develop severe AD-like tangle pathology at an age of seven to ten months [32]. The gene discussed is MAPT; the disease is Alzheimer disease.